Author Correction: Serum GFAP as a biomarker for disease severity in multiple sclerosis

Detalles Bibliográficos
Autores principales: Abdelhak, A., Huss, A., Kassubek, J., Tumani, H., Otto, M.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2019
Materias:
Author Correction
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6548773/
https://www.ncbi.nlm.nih.gov/pubmed/31164658
http://dx.doi.org/10.1038/s41598-019-43990-1
_version_ 1783423868152578048
author Abdelhak, A.
Huss, A.
Kassubek, J.
Tumani, H.
Otto, M.
author_facet Abdelhak, A.
Huss, A.
Kassubek, J.
Tumani, H.
Otto, M.
author_sort Abdelhak, A.
collection PubMed
description
format Online
Article
Text
id pubmed-6548773
institution National Center for Biotechnology Information
language English
publishDate 2019
publisher Nature Publishing Group UK
record_format MEDLINE/PubMed
spelling pubmed-65487732019-06-12 Author Correction: Serum GFAP as a biomarker for disease severity in multiple sclerosis Abdelhak, A. Huss, A. Kassubek, J. Tumani, H. Otto, M. Sci Rep Author Correction Nature Publishing Group UK 2019-06-05 /pmc/articles/PMC6548773/ /pubmed/31164658 http://dx.doi.org/10.1038/s41598-019-43990-1 Text en © The Author(s) 2019 Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons license, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons license and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this license, visit http://creativecommons.org/licenses/by/4.0/.
spellingShingle Author Correction
Abdelhak, A.
Huss, A.
Kassubek, J.
Tumani, H.
Otto, M.
Author Correction: Serum GFAP as a biomarker for disease severity in multiple sclerosis
title Author Correction: Serum GFAP as a biomarker for disease severity in multiple sclerosis
title_full Author Correction: Serum GFAP as a biomarker for disease severity in multiple sclerosis
title_fullStr Author Correction: Serum GFAP as a biomarker for disease severity in multiple sclerosis
title_full_unstemmed Author Correction: Serum GFAP as a biomarker for disease severity in multiple sclerosis
title_short Author Correction: Serum GFAP as a biomarker for disease severity in multiple sclerosis
title_sort author correction: serum gfap as a biomarker for disease severity in multiple sclerosis
topic Author Correction
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6548773/
https://www.ncbi.nlm.nih.gov/pubmed/31164658
http://dx.doi.org/10.1038/s41598-019-43990-1
work_keys_str_mv AT abdelhaka authorcorrectionserumgfapasabiomarkerfordiseaseseverityinmultiplesclerosis
AT hussa authorcorrectionserumgfapasabiomarkerfordiseaseseverityinmultiplesclerosis
AT kassubekj authorcorrectionserumgfapasabiomarkerfordiseaseseverityinmultiplesclerosis
AT tumanih authorcorrectionserumgfapasabiomarkerfordiseaseseverityinmultiplesclerosis
AT ottom authorcorrectionserumgfapasabiomarkerfordiseaseseverityinmultiplesclerosis

Ejemplares similares